CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Jun 15, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
100.0%
0.0% vs 52w high · +5.0% 1mo

Price (last ~year)

CVS Health Corp, currently trading at $101.96, has gained 40.8% over the last three months and beaten earnings estimates for four consecutive quarters, most recently reporting $2.57 per share for the period ending March 31, 2026. The company holds a $130.09B market cap and $405.62B in trailing twelve-month revenue, though it faces ongoing regulatory scrutiny regarding Medicare Advantage and carries $78.34B in total debt.

Valuation

Market cap
$130.09B
P/E
44.72
PEG
0.287
P/B
1.68
P/S
0.321
EV/EBITDA
17.66
Beta
0.623
Analyst target
$104.5

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$101.96
1-month
+5.0%
3-month
+40.8%
RSI (14)
71
vs SMA200
+29.5%
52-wk position
100.0% 0.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots